Ian Dawkins

发表

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.

C. Watson, K. McDonald, V. Voon, 2013, JAMA.

Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care.

J. Hayden, K. McDonald, M. Ledwidge, 2011, Clinical therapeutics.

A retrospective observational study of acquired subglottic stenosis using low‐pressure, high‐volume cuffed endotracheal tubes

D. Greaney, J. Russell, M. Healy, 2018, Paediatric anaesthesia.

Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone.

D. Phelan, C. Watson, K. McDonald, 2009, Journal of the American College of Cardiology.

B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent’s Screening TO Prevent Heart Failure) study

C. Kelleher, C. O’loughlin, K. McDonald, 2011, Clinical chemistry and laboratory medicine.

Associates of an Elevated Natriuretic Peptide Level in Stable Heart Failure Patients: Implications for Targeted Management

P. Collier, C. Watson, K. McDonald, 2013, TheScientificWorldJournal.

Screening to prevent heart failure (STOP‐HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction

K. McDonald, M. Ledwidge, G. Murtagh, 2012, European journal of heart failure.

Aspirin Use in Heart Failure: Is Low-Dose Therapy Associated With Mortality and Morbidity Benefits in a Large Community Population?

J. Gilmer, K. McDonald, M. Ledwidge, 2014, Circulation. Heart failure.

Aspirin Use in Heart Failure: Is Low Dose Therapy Associated with Mortality and Morbidity Benefits in a Large Community Population? Bermingham Et Al: Low-dose Aspirin and Mortality in Heart Failure

J. Gilmer, K. McDonald, M. Ledwidge, 2022 .